Medicare Enrolled

Dr. Edsel Hesita, M.D.

Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
11130 CHRISTUS HLS STE 210, San Antonio, TX 78251
2102452000
In practice since 2006 (19 years)
NPI: 1639102064 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hesita from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hesita? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hesita

Dr. Edsel Hesita is a medical oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hesita performed 30,408 Medicare services across 2,786 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hesita received a total of $2,178 from 31 pharmaceutical and/or device companies across 71 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hesita is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 30% volume in TX $2,178 industry payments

Medicare Practice Summary

Medicare Utilization ↗
30,408
Medicare services
Top 30% in TX for medical oncology
2,786
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,600 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 16,200 $0 $2
Anti-nausea injection (fosaprepitant) 6,150 $0 $5
Injection, granisetron hydrochloride, 100 mcg 1,060 $0 $24
Dexamethasone injection (steroid) 804 $0 $1
Complete blood count (CBC) with differential 678 $8 $36
Blood draw (venipuncture) 651 $8 $20
Comprehensive metabolic blood panel 513 $10 $64
Flow cytometry, additional marker 495 $18 $180
Anti-nausea injection (Aloxi/palonosetron) 450 $1 $114
Office visit, established patient (20-29 min) 400 $59 $250
Immunoglobulin level test 282 $9 $56
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 275 $21 $157
Administration of chemotherapy into vein, 1 hour or less 210 $95 $707
Office visit, established patient (30-39 min) 205 $90 $368
Drug injection, under skin or into muscle 176 $10 $96
Measurement of immunoglobulin light chains 170 $17 $60
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 149 $44 $313
New patient office visit (45-59 min) 135 $112 $565
Injection, zoledronic acid, 1 mg 134 $7 $431
Ferritin level test (iron stores) 109 $13 $60
Iron level test 109 $6 $27
Iron binding capacity test 109 $9 $35
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 98 $52 $211
Beta-2 microglobulin (protein) level 82 $16 $96
Administration of chemotherapy into vein, each additional hour 71 $21 $161
Hospital follow-up visit, moderate complexity 58 $59 $247
Injection, diphenhydramine hcl, up to 50 mg 58 $1 $7
Hospital follow-up visit, high complexity 52 $81 $357
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 49 $20 $128
Lactate dehydrogenase (enzyme) level 45 $6 $31
Administration of additional new drug or substance into vein, 1 hour or less 41 $47 $344
Initial hospital admission, moderate complexity 40 $97 $470
Unclassified drugs 36 $1 $8
Manual urinalysis test with examination using microscope, non-automated 33 $4 $26
Irrigation of implanted venous access drug delivery device 27 $18 $114
Protein measurement, serum 26 $11 $99
Immunologic analysis technique on serum (immunofixation) 26 $22 $160
Microscopic examination for white blood cells with manual cell count 25 $4 $22
Complete blood count (CBC), automated 25 $6 $34
Prothrombin time test (blood clotting) 22 $4 $30
Carcinoembryonic antigen (cea) protein level 21 $19 $99
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 21 $86 $657
Infusion, normal saline solution , 1000 cc 21 $2 $19
Flow cytometry technique for dna or cell analysis, first marker 20 $56 $298
Nuclear medicine study from skull base to mid-thigh with ct scan 17 $1,050 $4,802
Vitamin B-12 level test 16 $15 $76
Folic acid level test 14 $14 $73
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
83.6% medium
14.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,178
Total received (2018-2024)
Avg $311/year across 7 years
Bottom 40% in TX for medical oncology
31
Companies
71
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,101 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78 (3.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$382
2023
$612
2022
$261
2021
$152
2020
$97
2019
$420
2018
$254

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$533
E.R. Squibb & Sons, L.L.C.
$201
PFIZER INC.
$182
Janssen Biotech, Inc.
$147
Genmab U.S., Inc.
$125
ImmunoGen, Inc.
$125
AstraZeneca Pharmaceuticals LP
$101
Amgen Inc.
$97
ABBVIE INC.
$70
Lilly USA, LLC
$60
Bayer HealthCare Pharmaceuticals Inc.
$52
Genentech USA, Inc.
$52
Kite Pharma, Inc.
$46
Novartis Pharmaceuticals Corporation
$35
Celgene Corporation
$34
Pharmacyclics LLC, An AbbVie Company
$34
Merck Sharp & Dohme Corporation
$29
Janssen Pharmaceuticals, Inc
$27
Exelixis Inc.
$26
Seagen Inc.
$21
Kyowa Kirin, Inc.
$20
Daiichi Sankyo Inc.
$20
Merck Sharp & Dohme LLC
$18
Ipsen Biopharmaceuticals, Inc
$18
Sobi, Inc
$18
Regeneron Healthcare Solutions, Inc.
$17
Taiho Oncology, Inc.
$16
Astellas Pharma US Inc
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Array BioPharma Inc.
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 42.0% of total payments
Associated products mentioned in payments ›
AKYNZEO · ALIMTA · Abraxane · Braftovi · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · EMPLICITI · ENHERTU · ERLEADA · Elahere · Epkinly · GAZYVA · INJECTAFER · Imbruvica · KEYTRUDA · Kyprolis · LIBTAYO · LINZESS · LONSURF · LYNPARZA · MYRISK · Neulasta · Nplate · OPDIVO · PADCEV · POTELIGEO · PRECISETUMOR · PROMACTA · REBLOZYL · SOMATULINE DEPOT · Stivarga · TECENTRIQ · TIVDAK · VERZENIO · VIBERZI · Vitrakvi · XARELTO · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a medical oncology specialist in San Antonio?
Compare medical oncologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
37
Per 100K population
1.8
County median income
$70,571
Nearest hospital
WESTOVER HILLS BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hesita is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hesita experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Hesita performed 16,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hesita receive payments from pharmaceutical companies?
Yes. Dr. Hesita received a total of $2,178 from 31 companies across 71 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hesita's costs compare to other medical oncologists in San Antonio?
Dr. Hesita's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hesita) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →